Portugal LNG Webcast : Talk 1: European Union Orphan Drug Designation – Regulatory Considerations Talk 2: To Challenge and to be Challenged – Rare People and Orphan Medicines

Chapter EventsChapter Events Virtual ProgramsVirtual Programs EuropeEurope
EuropeGlobalPharmaceuticalsProduct Lifecycle